KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Net Cash Flow (2016 - 2026)

Abbott Laboratories' Net Cash Flow history spans 18 years, with the latest figure at -$1.7 billion for Q1 2026.

  • On a quarterly basis, Net Cash Flow fell 53.07% to -$1.7 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $247.0 million, a 13.03% decrease, with the full-year FY2025 number at $835.0 million, up 2.33% from a year prior.
  • Net Cash Flow hit -$1.7 billion in Q1 2026 for Abbott Laboratories, down from $1.0 billion in the prior quarter.
  • Over the last five years, Net Cash Flow for ABT hit a ceiling of $1.3 billion in Q2 2022 and a floor of -$2.1 billion in Q1 2022.
  • Historically, Net Cash Flow has averaged -$164.9 million across 5 years, with a median of $162.0 million in 2023.
  • Biggest five-year swings in Net Cash Flow: crashed 269.71% in 2022 and later soared 612.77% in 2025.
  • Tracing ABT's Net Cash Flow over 5 years: stood at $237.0 million in 2022, then plummeted by 31.65% to $162.0 million in 2023, then dropped by 12.96% to $141.0 million in 2024, then soared by 612.77% to $1.0 billion in 2025, then crashed by 268.76% to -$1.7 billion in 2026.
  • Business Quant data shows Net Cash Flow for ABT at -$1.7 billion in Q1 2026, $1.0 billion in Q4 2025, and $570.0 million in Q3 2025.